Plasma vitamin B12 status and cerebral white-matter lesions

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 2, 2009, Pages 149-157

  De Lau, L M L ^a   Smith, A D ^b   Refsum, H ^b,c   Johnston, C ^b   Breteler, M M B ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN DERIVATIVE; CYANOCOBALAMIN; FOLIC ACID; HOLOTRANSCOBALAMIN; HOMOCYSTEINE; METHYLMALONIC ACID; MYELIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

AGED; ARTERY DIAMETER; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; BLOOD PRESSURE; BRAIN DAMAGE; BRAIN INFARCTION; COGNITION; CONCENTRATION (PARAMETERS); CONFOUNDING VARIABLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; VITAMIN BLOOD LEVEL; WHITE MATTER; BLOOD; BRAIN; BRAIN CIRCULATION; COGNITIVE DEFECT; HEALTH SURVEY; HOSPITALIZATION; METABOLISM; MYELIN SHEATH; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHYSIOLOGY; PREVALENCE; VASCULARIZATION;

AGED; BIOLOGICAL MARKERS; BRAIN; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYELIN SHEATH; NEUROPSYCHOLOGICAL TESTS; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITAMIN B 12;

EID: 60249089069     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.149286     Document Type: Article

References (44)

1. 12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449-55.
2. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-83.
3. Bots ML, Launer LJ, Lindemans J, et al. Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med 1999;159:38-44.
4. Vermeer SE, van Dijk EJ, Koudstaal PJ, et al. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol 2002;51:285-9.
5. Dufouil C, Alperovitch A, Ducros V, et al. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2003;53:214-21.
6. Nurk E, Refsum H, Tell GS, et al. Plasma total homocysteine and memory in the elderly: the Hordaland Homocysteine Study. Ann Neurol 2005;58:847-57.
7. Prins ND, Den Heijer T, Hofman A, et al. Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study. Neurology 2002;59:1375-80.
8. Selhub J, Bagley LC, Miller J, et al. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 2000;71:614-20S.
9. 12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med 2005;118:161-7.
10. Ramos MI, Allen LH, Mungas DM, et al. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. Am J Clin Nutr 2005;82:1346-52.
11. Iosifescu DV, Papakostas GI, Lyoo IK, et al. Brain MRI white matter hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I). Psychiatry Res 2005;140:291-9.
12. de Lau LM, Refsum H, Smith AD, et al. Plasma folate concentration and cognitive performance: Rotterdam Scan Study. Am J Clin Nutr 2007;86:728-34.
13. 12 predict white matter lesions in patients with major depression. J Affect Disord 2005;85:327-32.
14. Scott TM, Tucker KL, Bhadelia A, et al. Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. Am J Geriatr Psychiatry 2004;12:631-8.
15. Lewerin C, Matousek M, Steen G, et al. Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study. Am J Clin Nutr 2005;81:1155-62.
16. Garcia AA, Haron Y, Evans LR, et al. Metabolic markers of cobalamin deficiency and cognitive function in normal older adults. J Am Geriatr Soc 2004;52:66-71.
17. McCracken C, Hudson P, Ellis R, et al. Methylmalonic acid and cognitive function in the Medical Research Council Cognitive Function and Ageing Study. Am J Clin Nutr 2006;84:1406-11.
18. Refsum H, Smith AD. Low vitamin B-12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalamin. J Neurol Neurosurg Psychiatry 2003;74:959-61.
19. Mooijaart SP, Gussekloo J, Frolich M, et al. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study. Am J Clin Nutr 2005;82:866-71.
20. Campbell AK, Jagust WJ, Mungas DM, et al. Low erythrocyte folate, but not plasma vitamin B-12 or homocysteine,is associated with dementia in elderly Latinos. J Nutr Health Aging 2005;9:39-43.
21. Hvas AM, Nexo E. Holotranscobalamin - a first choice assay for diagnosing early vitamin B deficiency? J Intern Med 2005;257:289- 98.
22. 12. Clin Chem 2004;50:1043-9.
23. Refsum H, Johnston C, Guttormsen AB, et al. Holotranscobalamin and total transcobalamin in human plasma: determination, determinants, and reference values in healthy adults. Clin Chem 2006;52:129-37.
24. Devalia V. Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay. BMJ 2006;333:385-6.
25. Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005;128:2034-41.
26. 12 with use of a colistin-sulfate-resistant organism. Clin Chem 1987;33:52-4.
27. Husek P. Simultaneous profile analysis of plasma amino and organic acids by capillary gas chromatography. J Chromatogr B Biomed Appl 1995;669:352-7.
28. de Groot JC, de Leeuw FE, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000;47:145-51.
29. 12 study. Age Ageing 2006;35:416-22.
30. 12 deficiency. Neurology 1997;49:878-81.
31. 12-deficiency causing isolated and partially reversible leukoencephalopathy. J Neurol 2005;252:980-2.
32. 12 deficiency myelopathy. Can J Neurol Sci 1999;26:60-3.
33. Scalabrino G. Cobalamin (vitamin B(12)) in subacute combined degeneration and beyond: traditional interpretations and novel theories. Exp Neurol 2005;192:463-79.
34. Tucker KL, Qiao N, Scott T, et al. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 2005;82:627-35.
35. Smith AD. The worldwide challenge of the dementias: A role for B vitamins and homocysteine? Food Nutr Bull 2008;29:143-72S.
36. 12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med 2007;167:21-30.
37. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683-9.
38. Ovbiagele B, Saver JL. Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications. Cerebrovasc Dis 2006;22:83-90.
39. Amar K, Lewis T, Wilcock G, et al. The relationship between white matter low attenuation on brain CT and vascular risk factors: a memory clinic study. Age Ageing 1995;24:411-15.
40. Rossi R, Joachim C, Geroldi C, et al. Pathological validation of a CT-based scale for subcortical vascular disease. The OPTIMA Study. Dement Geriatr Cogn Disord 2005;19:61-6.
41. James SJ, Melnyk S, Pogribna M, et al. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 2002;132(8 Suppl):2361-6S.
42. 12 deficiency. Neurosci Lett 2000;288:191-4.
43. Scott JM, Dinn JJ, Wilson P, et al. Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet 1981;2:334-7.
44. Kim S, Lim IK, Park GH, et al. Biological methylation of myelin basic protein: enzymology and biological significance. Int J Biochem Cell Biol 1997;29:743-51.